Reformulary Group announces Cannabis Standard, Canada’s first evidence-based medical cannabis formulary

X

Reformulary 2018 Year in Review

Reformulary 2018 Year in Review

Our 2018 year in review: From Plan Sustainability to Insights to Innovations. See how we are making a Remarkable difference.

Click here to review our 2018 Year in Review